Antibody-drug conjugates (ADCs) are promising biotherapeutic candidates that combine highly potent cytotoxic drugs with monoclonal antibodies (mAbs) for targeted drug delivery in the treatment of ...

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

Appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development. Pharmaceutical companies walk a tightrope in early drug development.

Delve into the heart of vaccine development with our three-day virtual masterclass, guided by the esteemed Dr. Tudor Arvinte. This immersive course offers a unique blend of scientific rigor and ...

LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers ...